These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 7909149)
21. Recent advances in atypical antipsychotics. Armer R; Miller DJ Curr Opin Investig Drugs; 2000 Dec; 1(4):481-93. PubMed ID: 11249703 [No Abstract] [Full Text] [Related]
22. Welcome to the April '12 issue of Clinical Schizophrenia and Related Psychoses (CS). Introduction. Buckley PF Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):4. PubMed ID: 22570918 [No Abstract] [Full Text] [Related]
23. [Cognitive deficits in schizophrenia and other psychotic disorders]. Fagerlund B; Glenthøj BY Ugeskr Laeger; 2008 Nov; 170(46):3770-2. PubMed ID: 19014728 [TBL] [Abstract][Full Text] [Related]
24. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect: effective and free of side effects]. Fortschr Neurol Psychiatr; 1998 Oct; 66(10 Suppl Schizophre):1-4. PubMed ID: 9828949 [No Abstract] [Full Text] [Related]
25. [Schizophrenic chronicity due to neuroleptics?]. Cornu F Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(2):269-73. PubMed ID: 6109373 [No Abstract] [Full Text] [Related]
26. Antipsychotic prescribing patterns in the Texas prison system. Baillargeon J; Contreras SA J Am Acad Psychiatry Law; 2001; 29(1):48-53. PubMed ID: 11302386 [TBL] [Abstract][Full Text] [Related]
27. A pilot study of the safety and tolerance of SCH 39166 in patients with schizophrenia. Labelle A; de Beaurepaire R; Boulay LJ; Naber D; Jones BD; Barnes TR J Psychiatry Neurosci; 1998 Mar; 23(2):93-4. PubMed ID: 9549248 [No Abstract] [Full Text] [Related]
28. Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses. Turner MS; Stewart DW J Psychopharmacol; 2006 Nov; 20(6 Suppl):20-37. PubMed ID: 17046985 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study. Landry P; Dimitri E; Tessier S; Légaré N J Clin Psychopharmacol; 2008 Jun; 28(3):348-9. PubMed ID: 18480696 [No Abstract] [Full Text] [Related]
30. [For: is monotherapy the gold standard of psychopharmacology?]. Fehr C Psychiatr Prax; 2006 Jul; 33(5):207-8. PubMed ID: 16802258 [No Abstract] [Full Text] [Related]
31. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients. Schneider AL; Mosier KE; Tempier RP J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492 [No Abstract] [Full Text] [Related]
32. Outcomes of an early psychosis intervention program. Pelosi AJ Aust N Z J Psychiatry; 2005 Jun; 39(6):522-3; author reply 523-4, 525-6. PubMed ID: 15943656 [No Abstract] [Full Text] [Related]
33. [Ziprasidone. A new second-generation antipsychotic agent]. Lublin HK Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124 [No Abstract] [Full Text] [Related]
34. Pharmacokinetics and safety of combination therapy with lithium and risperidone. Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646 [No Abstract] [Full Text] [Related]
35. Letter to the Editor: haloperidol but not dopamine rapidly induces neuronal death: comments on 'A systematic review of the effects of antipsychotic drugs on brain volume'. Grant P Psychol Med; 2013 Jul; 43(7):1568. PubMed ID: 23651623 [No Abstract] [Full Text] [Related]
38. [An analysis of efficacy and safety of modern and classical antipsychotic drugs]. Tsygankov BD; Agasarian EG Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(9):64-70. PubMed ID: 17069067 [No Abstract] [Full Text] [Related]